Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A13002 | Pages: 216 | Charts: 69 | Tables: 106 |
The global vitamin E market size was valued at $2,661.1 million in 2020, and is projected to reach $3,728.2 million by 2028, registering a CAGR of 4.3%. Asia-Pacific was the highest revenue contributor, accounting for $1,016.8 million in 2020, and is estimated to reach $1,528.9 million by 2028, with a CAGR of 5.3%.
Vitamin E is an essential fat-soluble vitamin protecting cell membranes from reactive oxygen species. It is a cluster of eight fat soluble composites which include tocotrienols and tocopherols. The deficiency of vitamin E, is rare and occurs usually owing to a casual problem with digesting dietary fat rather than from a low in vitamin E diet, which can further cause nerve problems. Vitamin E is an essential nutrient that helps combat oxidative damage to the cells of human and animals. It also help prevent a number of life threatening diseases such as cancer, chronic pancreatitis, cholestasis, cystic fibrosis, primary biliary cirrhosis, Crohn's disease, short bowel syndrome and more among others
The food & beverage industry as a whole had been growing at a significant growth rate prior to the COVID-19 outbreak, however, has experienced a decline in growth rate in the recent time, as consumers are being selective on their purchases. The disruption of supply chain has further disrupted the availability of products. Although the consumption of out-of-house food may have witnessed a standstill, the consumption of food in-house has remained the same and in some cases have increased. Moreover, consumption of health food and supplements has increased drastically, owing to the fact that consumers have shifted their preference toward food that improve immunity.
Get more information on this report : Request Sample Pages
Vitamin E falls in the category of products, which are purchased by consumers occasionally. Hence, the demand for such products remains consistent among the consumers. The outbreak of the novel coronavirus has significantly affected the growth of the Vitamin E market in a positive manner. There has been a slight increase in the sales of vitamins and mineral supplements and medication. This increase in growth in the Vitamin market is majorly attributed to the rise in concerns about health and surge in the knowledge about the nutrition among the general populace.
The growth of the Vitamin E market is attributed to widespread promotion and advertisements regarding the importance of consuming vitamin E and the disadvantages of having its deficiency. Moreover, the easily availability is the factor which smoothens the requirement and sales of vitamin E in the market. . In addition, there are many sales channel like Apollo online pharmacy and internet pharmacy which are quick in delivering the requirements with available discounts. Moreover, many supplements and cosmetics are also available over the popular online retailers like Amazon, Grofers, ubuy, Walmart, and other websites. Therefore, surge in number of distribution channels and easy availability of the supplements propels the market growth of vitamin E. However, easy availability of substitute act as the restraint for the market. Conversely, increase in the demand of Vitamin E in the processed food and pet nutrition is expected to make way for Vitamin E market growth.
The global Vitamin E market is segmented on the basis of type, application, and region. On the basis of type, the market is bifurcated into natural and synthetic. On the basis of application, the market is categorized into supplements, cosmetic and animal feeds. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and rest of Europe), Asia-Pacific (China, India, Japan, ASEAN, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East and Africa).
Based on Vitamin E market analysis by type, the synthetic segment accounted for the majority of the share in the global vitamin E market in 2020. The synthetic segment was also the fastest growing segment in the type category. The growth in this segment can be attributed to easy availability and cost effectiveness of this segment.
[TYPEGRAPH]
Get more information on this report : Request Sample Pages
Based on Vitamin E market forecast by application, the supplement segment was the largest and fastest growing segment in 2020. The growth in this segment can be attributed to the growing awareness about diet and nutrition among the general populace. The cosmetic segment in the application category is expected to garner modest growth in the coming years, with a CAGR of 4.1% from 2021-2028.
[APPLICATIONGRAPH]
Get more information on this report : Request Sample Pages
Based on the region, Asia-Pacific was the dominant regional market accounting for more than one-third of the global revenue in 2020. Asia-Pacific was also the fastest growing regional segment throughout the forecast period.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
The key players in the Vitamin E industry have relied on product launch as their key strategy to stay relevant in the Vitamin E market share. The key players operating in the vitamin E market include- Advanced Organic Materials, SA, Antares Health Products, Inc., Archer Daniels Midland Company, BASF Nutrition, BTSA Biotecnologías Aplicadas, S.L., Koninklijke Dsm N.V., Matrix Fine Sciences Pvt. Ltd., Merck KGAA, N.S. Chemicals and The Nature’s Bounty Co
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.5.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Vitamin E market snapshot
2.2.Key findings of the study
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Top player positioning
3.4.Porter's five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in demand for dietary supplements
3.5.1.2.Increase in occurrence of diseases augments the demand for vitamin E in the market.
3.5.1.3.Easy availability of the products drives the market growth
3.5.2.Restraints
3.5.2.1.Easy availability of substitutes is hampering the market growth
3.5.2.2.Counterfeited vitamin E cosmetics is pushing away the consumer’s trust
3.5.3.Opportunity
3.5.3.1.Rise in demand for organic cosmetic with vitamin E
3.5.3.2.Gummies will be the future of consuming vitamins instead of pills
3.6.Pricing analysis
3.7.COVID-19 impact analysis
3.7.1.Introduction
3.7.2.Impact on Vitamin E market
3.8.Value chain analysis
3.9.Production process of Vitamin E
3.10.Production capacity of top countries
CHAPTER 4:VITAMIN E MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Natural
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market size and forecast, by country
4.3.Synthetic
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by country
CHAPTER 5:VITAMIN E MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Supplement
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market size and forecast, by country
5.3.Cosmetics
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market size and forecast, by country
5.4.Animal Feed
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market size and forecast, by country
CHAPTER 6:VITAMIN E MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.4.1.U.S.
6.2.4.1.1.Market size and forecast, by type
6.2.4.1.2.Market size and forecast, by application
6.2.4.2.Canada
6.2.4.2.1.Market size and forecast, by type
6.2.4.2.2.Market size and forecast, by application
6.2.4.3.Mexico
6.2.4.3.1.Market size and forecast, by type
6.2.4.3.2.Market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country
6.3.4.1.Germany
6.3.4.1.1.Market size and forecast, by type
6.3.4.1.2.Market size and forecast, by application
6.3.4.2.UK
6.3.4.2.1.Market size and forecast, by type
6.3.4.2.2.Market size and forecast, by application
6.3.4.3.France
6.3.4.3.1.Market size and forecast, by type
6.3.4.3.2.Market size and forecast, by application
6.3.4.4.Italy
6.3.4.4.1.Market size and forecast, by type
6.3.4.4.2.Market size and forecast, by application
6.3.4.5.Spain
6.3.4.5.1.Market size and forecast, by type
6.3.4.5.2.Market size and forecast, by application
6.3.4.6.Russia
6.3.4.6.1.Market size and forecast, by type
6.3.4.6.2.Market size and forecast, by application
6.3.4.7.Rest of Europe
6.3.4.7.1.Market size and forecast, by type
6.3.4.7.2.Market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.4.1.China
6.4.4.1.1.Market size and forecast, by type
6.4.4.1.2.Market size and forecast, by application
6.4.4.2.India
6.4.4.2.1.Market size and forecast, by type
6.4.4.2.2.Market size and forecast, by application
6.4.4.3.Japan
6.4.4.3.1.Market size and forecast, by type
6.4.4.3.2.Market size and forecast, by application
6.4.4.4.ASEAN
6.4.4.4.1.Market size and forecast, by type
6.4.4.4.2.Market size and forecast, by application
6.4.4.5.South Korea
6.4.4.5.1.Market size and forecast, by type
6.4.4.5.2.Market size and forecast, by application
6.4.4.6.Australia
6.4.4.6.1.Market size and forecast, by type
6.4.4.6.2.Market size and forecast, by application
6.4.4.7.Rest of Asia-Pacific
6.4.4.7.1.Market size and forecast, by type
6.4.4.7.2.Market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country
6.5.4.1.Latin America
6.5.4.1.1.Market size and forecast, by type
6.5.4.1.2.Market size and forecast, by application
6.5.4.2.Middle East
6.5.4.2.1.Market size and forecast, by type
6.5.4.2.2.Market size and forecast, by application
6.5.4.3.Africa
6.5.4.3.1.Market size and forecast, by type
6.5.4.3.2.Market size and forecast, by application
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Product mapping
7.3.Competitive dashboard
7.4.Competitive heat map
CHAPTER 8:COMPANY PROFILES
8.1.ADVANCED ORGANIC MATERIALS, SA
8.1.1.Company overview
8.1.2.Key Executives
8.1.3.Company snapshot
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.1.6.SWOT Analysis
8.2.ANTARES HEALTH PRODUCTS, INC.
8.2.1.Company overview
8.2.2.Key Executives
8.2.3.Company snapshot
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.2.6.SWOT Analysis
8.3.ARCHER DANIELS MIDLAND COMPANY
8.3.1.Company overview
8.3.2.Key executives
8.3.3.Company snapshot
8.3.4.Operating business segments
8.3.5.Product portfolio
8.3.6.R&D Expenditure
8.3.7.Business performance
8.3.8.Key strategic moves and developments
8.3.9.SWOT Analysis
8.4.BASF NUTRITION
8.4.1.Company overview
8.4.2.Key Executives
8.4.3.Company snapshot
8.4.4.Operating business segments
8.4.5.Product portfolio
8.4.6.Business performance
8.4.7.SWOT Analysis
8.5.BTSA BIOTECNOLOGÍAS APLICADAS, S.L.
8.5.1.Company overview
8.5.2.Key Executives
8.5.3.Company snapshot
8.5.4.Product portfolio
8.5.5.SWOT Analysis
8.6.KONINKLIJKE DSM N.V.
8.6.1.Company overview
8.6.2.Key Executives
8.6.3.Company snapshot
8.6.4.Operating business segments
8.6.5.Product portfolio
8.6.6.R&D Expenditure
8.6.7.Business performance
8.6.8.Key strategic moves and developments
8.6.9.SWOT Analysis
8.7.MATRIX FINE SCIENCES PVT. LTD.
8.7.1.Company overview
8.7.2.Key Executives
8.7.3.Company snapshot
8.7.4.Product portfolio
8.7.5.Key strategic moves and developments
8.7.6.SWOT Analysis
8.8.MERCK KGAA
8.8.1.Company overview
8.8.2.Key Executives
8.8.3.Company snapshot
8.8.4.Operating business segments
8.8.5.Product portfolio
8.8.6.R&D Expenditure
8.8.7.Business performance
8.8.8.SWOT Analysis
8.9.N.S. CHEMICALS
8.9.1.Company overview
8.9.2.Key Executives
8.9.3.Company snapshot
8.9.4.Product portfolio
8.9.5.SWOT Analysis
8.10.THE NATURE’S BOUNTY CO.
8.10.1.Company overview
8.10.2.Key Executives
8.10.3.Company snapshot
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
8.10.6.SWOT Analysis
LIST OF TABLES
TABLE 01.NORTH AMERICA PRICE ANALYSIS, 2020
TABLE 02.EUROPE PRICE ANALYSIS, 2020
TABLE 03.ASIA-PACIFIC PRICE ANALYSIS, 2020
TABLE 04.LAMEA PRICE ANALYSIS, 2020
TABLE 05.ESTIMATED PRODUCTION CAPACITIES OF TOP COUNTRIES
TABLE 06.VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 07.NATURAL VITAMIN E MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 08.SYNTHETIC VITAMIN E MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 09.VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 10.VITAMIN E MARKET FOR SUPPLEMENT, BY REGION, 2020-2028 ($MILLION)
TABLE 11.VITAMIN E MARKET FOR COSMETICS, BY REGION, 2020-2028 ($MILLION)
TABLE 12.VITAMIN E MARKET FOR ANIMAL FEED, BY REGION, 2020-2028 ($MILLION)
TABLE 13.VITAMIN E MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 14.NORTH AMERICA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 15.NORTH AMERICA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 16.NORTH AMERICA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 17.U.S. VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 18.U.S. VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 19.CANADA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 20.CANADA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 21.MEXICO VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 22.MEXICO VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 23.EUROPE VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 24.EUROPE VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 25.EUROPE VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 26.GERMANY VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 27.GERMANY VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 28.UK VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 29.UK VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 30.FRANCE VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 31.FRANCE VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 32.ITALY VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 33.ITALY VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 34.SPAIN VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 35.SPAIN VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 36.RUSSIA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 37.RUSSIA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 38.REST OF EUROPE VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 39.REST OF EUROPE VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 40.ASIA-PACIFIC VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 41.ASIA-PACIFIC VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 42.ASIA-PACIFIC VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 43.CHINA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 44.CHINA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 45.INDIA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 46.INDIA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 47.JAPAN VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 48.JAPAN VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 49.ASEAN VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 50.ASEAN VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 51.SOUTH KOREA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 52.SOUTH KOREA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 53.AUSTRALIA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 54.AUSTRALIA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 56.REST OF ASIA-PACIFIC VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 57.LAMEA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 58.LAMEA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 59.LAMEA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 60.LATIN AMERICA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 61.LATIN AMERICA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 62.MIDDLE EAST VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 63.MIDDLE EAST VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 64.AFRICA VITAMIN E MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 65.AFRICA VITAMIN E MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 66.ADVANCED ORGANIC MATERIALS, SA: KEY EXECUTIVES
TABLE 67.ADVANCED ORGANIC MATERIALS, SA: COMPANY SNAPSHOT
TABLE 68.ADVANCED ORGANIC MATERIALS, SA: PRODUCT PORTFOLIO
TABLE 69.ANTARES HEALTH PRODUCTS, INC.: KEY EXECUTIVES
TABLE 70.ANTARES HEALTH PRODUCTS, INC.: COMPANY SNAPSHOT
TABLE 71.ANTARES HEALTH PRODUCTS, INC.: PRODUCT PORTFOLIO
TABLE 72.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVES
TABLE 73.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 74.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 75.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 76.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 77.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018–2020 ($MILLION)
TABLE 78.BASF NUTRITION: KEY EXECUTIVES
TABLE 79.BASF NUTRITION: COMPANY SNAPSHOT
TABLE 80.BASF NUTRITION: OPERATING SEGMENTS
TABLE 81.BASF NUTRITION: PRODUCT PORTFOLIO
TABLE 82.BASF NUTRITION: NET SALES, 2018–2020 ($MILLION)
TABLE 83.BTSA BIOTECNOLOGÍAS APLICADAS, S.L.: KEY EXECUTIVES
TABLE 84.BTSA BIOTECNOLOGÍAS APLICADAS, S.L.: COMPANY SNAPSHOT
TABLE 85.BTSA BIOTECNOLOGÍAS APLICADAS, S.L.: PRODUCT PORTFOLIO
TABLE 86.KONINKLIJKE DSM N.V.: KEY EXECUTIVES
TABLE 87.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 88.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
TABLE 89.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 90.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 91.KONINKLIJKE DSM N.V.: NET SALES, 2018–2020 ($MILLION)
TABLE 92.MATRIX FINE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 93.MATRIX FINE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 94.MATRIX FINE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 95.MERCK KGAA: KEY EXECUTIVES
TABLE 96.MERCK KGAA: COMPANY SNAPSHOT
TABLE 97.MERCK KGAA: OPERATING SEGMENTS
TABLE 98.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 99.MERCK KGAA: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 100.MERCK KGAA: NET SALES, 2018–2020 ($MILLION)
TABLE 101.N.S. CHEMICALS: KEY EXECUTIVES
TABLE 102.N.S. CHEMICALS: COMPANY SNAPSHOT
TABLE 103.N.S. CHEMICALS: PRODUCT PORTFOLIO
TABLE 104.THE NATURE’S BOUNTY CO.: KEY EXECUTIVES
TABLE 105.THE NATURE’S BOUNTY CO.: COMPANY SNAPSHOT
TABLE 106.THE NATURE’S BOUNTY CO.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.VITAMIN E MARKET SEGMENTATION
FIGURE 02.VITAMIN E MARKET, 2020–2028
FIGURE 03.TOP INVESTMENT POCKET, BY COUNTRY
FIGURE 04.TOP PLAYER POSITIONING, 2020
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.LOW THREAT OF NEW ENTRANTS
FIGURE 08.LOW THREAT OF SUBSTITUTES
FIGURE 09.LOW INTENSITY OF COMPETITIVE RIVALRY
FIGURE 10.VITAMIN E MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 11.VALUE CHAIN ANALYSIS: VITAMIN E MARKET
FIGURE 12.VITAMIN E MARKET, BY TYPE, 2020 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NATURAL VITAMIN E MARKET, BY COUNTRY, 2020-2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SYNTHETIC VITAMIN E MARKET, BY COUNTRY, 2020-2028 (%)
FIGURE 15.VITAMIN E MARKET, BY APPLICATION, 2020 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VITAMIN E MARKET FOR SUPPLEMENT, BY COUNTRY, 2020-2028 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VITAMIN E MARKET FOR COSMETICS, BY COUNTRY, 2020-2028 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF VITAMIN E MARKET FOR ANIMAL FEED, BY COUNTRY, 2020-2028 (%)
FIGURE 19.VITAMIN E MARKET, BY REGION, 2020 (%)
FIGURE 20.U.S. VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 21.CANADA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 22.MEXICO VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 23.GERMANY VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 24.UK VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 25.FRANCE VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 26.ITALY VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 27.SPAIN VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 28.RUSSIA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 29.REST OF EUROPE VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 30.CHINA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 31.INDIA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 32.JAPAN VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 33.ASEAN VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 34.SOUTH KOREA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 35.AUSTRALIA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 37.LATIN AMERICA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 38.MIDDLE EAST VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 39.AFRICA VITAMIN E MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 40.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 41.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 42.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 43.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 44.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 46.ADVANCED ORGANIC MATERIALS, SA: SWOT ANALYSIS
FIGURE 47.ANTARES HEALTH PRODUCTS, INC.: SWOT ANALYSIS
FIGURE 48.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 49.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52.ARCHER DANIELS MIDLAND COMPANY: SWOT ANALYSIS
FIGURE 53.BASF NUTRITION: NET SALES, 2018–2020 ($MILLION)
FIGURE 54.BASF NUTRITION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 55.BASF NUTRITION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 56.BASF NUTRITION: SWOT ANALYSIS
FIGURE 57.BTSA BIOTECNOLOGÍAS APLICADAS, S.L.: SWOT ANALYSIS
FIGURE 58.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 59.KONINKLIJKE DSM N.V.: NET SALES, 2018–2020 ($MILLION)
FIGURE 60.KONINKLIJKE DSM N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 61.KONINKLIJKE DSM N.V.: SWOT ANALYSIS
FIGURE 62.MATRIX FINE SCIENCES PVT. LTD.: SWOT ANALYSIS
FIGURE 63.MERCK KGAA: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 64.MERCK KGAA: NET SALES, 2018–2020 ($MILLION)
FIGURE 65.MERCK KGAA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66.MERCK KGAA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 67.MERCK KGAA: SWOT ANALYSIS
FIGURE 68.N.S. CHEMICALS: SWOT ANALYSIS
FIGURE 69.THE NATURE’S BOUNTY CO.: SWOT ANALYSIS